{"id":"W4406869302","doi":"10.1200/jco.2025.43.4_suppl.4","title":"Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Basal cell; Oncology; Internal medicine; Anal canal; Bifunctional; Cancer research; Cancer; Immunotherapy; Rectum","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001473952,0.001197122,0.001244943,0.0004462924,0.0004489783,0.0007987017,0.0007340155,0.001206547,0.003221269],"category_scores_gemma":[0.0008266257,0.0004154789,0.001253398,0.0003313342,0.0006108007,0.000847355,0.0003244934,0.002965454,0.000700432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001156829,"about_ca_system_score_gemma":0.001271237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001567135,"about_ca_topic_score_gemma":0.003457744,"domain_scores_codex":[0.9995289,0.0002105262,0.00002108469,0.00007045109,0.00004058979,0.0001284015],"domain_scores_gemma":[0.9994055,0.0001010359,0.0001138689,0.0000520108,0.00004767898,0.0002798849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.422653,0.1620515,0.01331149,0.001241788,0.001714537,0.0005799648,0.0007278442,0.00632527,0.1832979,0.0003767718,0.009418378,0.1983016],"study_design_scores_gemma":[0.2139776,0.7434148,0.02094258,0.00005845076,0.0006213571,0.0005406459,0.00007541919,0.001414682,0.01405293,0.000213867,0.004657771,0.00002980997],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916719,0.001599645,0.0005384265,0.0004904452,0.00006209571,0.002648093,0.001130467,0.00008414378,0.001774932],"genre_scores_gemma":[0.9879403,0.001290847,0.00207833,0.0007727054,0.0001024582,0.002668474,0.003080665,0.00003650216,0.002029647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003221269,"threshold_uncertainty_score":0.01077622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02798824627886642,"score_gpt":0.3403073014110149,"score_spread":0.3123190551321485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}